Advances in LFAs for infectious diseases include nanomaterial engineering, CRISPR amplification, and multiplex designs for better sensitivity and quantitation. AI/ML enables smartphone-based objective analysis, despite standardization challenges, paving the way for connected PoC diagnostics.